Lau Alan W, Liu Pengda, Inuzuka Hiroyuki, Gao Daming
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School Boston, MA 02215, USA.
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School Boston, MA 02215, USA ; State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 320 Yue-Yang Road, Shanghai 200031, China.
Am J Cancer Res. 2014 May 26;4(3):245-55. eCollection 2014.
The deacetylase SIRT1 regulates multiple biological processes including cellular metabolism and aging. Importantly, SIRT1 can also inactivate the p53 tumor suppressor via deacetylation, suggesting a role in oncogenesis. Recently, SIRT1 was shown to be released from its endogenous inhibitor DBC1 by a process requiring AMPK and the phosphorylation of SIRT1 by yet undefined kinase(s). Here we provide further evidence that AMPK directly phosphorylates SIRT1 on T344, releasing it from DBC1. Furthermore, a phospho-mimetic SIRT1 (T334E) showed decreased binding to DBC1, supporting the importance of this phosphorylation in AMPK-mediated regulation of SIRT1 activity. In addition, inhibition of AMPK by Compound C led to increased p53 acetylation, suggesting a role for the AMPK/SIRT1 pathway in regulating p53 signaling. Together, our results support a hypothesis that AMPK negatively regulates p53 acetylation via phosphorylation of SIRT1 on T344. Furthermore, our findings also define the AMPK/SIRT1 axis as a possible targetable pathway to regulate p53 function.
去乙酰化酶SIRT1调节包括细胞代谢和衰老在内的多种生物学过程。重要的是,SIRT1还可通过去乙酰化使p53肿瘤抑制因子失活,提示其在肿瘤发生中发挥作用。最近研究表明,SIRT1可通过一种需要AMPK以及尚未明确的激酶对SIRT1进行磷酸化的过程,从其内源性抑制剂DBC1中释放出来。在此,我们提供进一步证据表明,AMPK直接使SIRT1的T344位点磷酸化,使其从DBC1中释放出来。此外,模拟磷酸化的SIRT1(T334E)与DBC1的结合减少,支持了这种磷酸化在AMPK介导的SIRT1活性调节中的重要性。另外,用化合物C抑制AMPK导致p53乙酰化增加,提示AMPK/SIRT1途径在调节p53信号传导中发挥作用。总之,我们的结果支持这样一种假说,即AMPK通过使SIRT1的T344位点磷酸化来负向调节p53乙酰化。此外,我们的研究结果还将AMPK/SIRT1轴定义为调节p53功能的一个可能的可靶向途径。